JOVIC, Gordana
 Distribuzione geografica
Continente #
NA - Nord America 2.002
EU - Europa 1.061
AS - Asia 356
AF - Africa 16
SA - Sud America 6
OC - Oceania 2
Totale 3.443
Nazione #
US - Stati Uniti d'America 1.986
GB - Regno Unito 258
SE - Svezia 191
IE - Irlanda 179
IT - Italia 173
CN - Cina 128
DE - Germania 95
SG - Singapore 86
UA - Ucraina 54
HK - Hong Kong 50
FI - Finlandia 38
TR - Turchia 32
BG - Bulgaria 19
LT - Lituania 19
IN - India 15
CA - Canada 12
ID - Indonesia 12
RU - Federazione Russa 12
VN - Vietnam 12
ET - Etiopia 7
FR - Francia 5
NL - Olanda 5
KE - Kenya 4
MY - Malesia 4
ES - Italia 3
IQ - Iraq 3
IR - Iran 3
MX - Messico 3
TW - Taiwan 3
AU - Australia 2
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
GR - Grecia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
BZ - Belize 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 3.443
Città #
Santa Clara 229
Fairfield 219
Southend 201
Chandler 182
Dublin 179
Woodbridge 155
Ashburn 140
Houston 132
Dearborn 118
Nyköping 109
Jacksonville 100
Seattle 85
Cambridge 81
Singapore 72
Wilmington 69
Ann Arbor 68
New York 48
Hong Kong 45
Beijing 41
Helsinki 24
Izmir 24
Modena 24
San Diego 24
Princeton 22
Eugene 19
Sofia 19
Milan 17
Dong Ket 12
Jakarta 12
London 12
Des Moines 11
Lansdale 11
Shanghai 11
Rome 9
Palermo 8
Bremen 7
Munich 7
Stockholm 6
Kunming 5
Nanjing 5
Phoenix 5
Tulsa 5
Bari 4
Falls Church 4
Gallarate 4
Guangzhou 4
Norwalk 4
Ottawa 4
Redwood City 4
San Mateo 4
Augusta 3
Bangalore 3
Boardman 3
Burlington 3
Chiswick 3
Cremona 3
Fremont 3
Hounslow 3
Madrid 3
Mexicali 3
Moscow 3
Nairobi 3
Naples 3
Padova 3
Taipei 3
Vicenza 3
Yuen Long San Hui 3
Amsterdam 2
Athens 2
Berlin 2
Corinaldo 2
Cortona 2
Dallas 2
Foligno 2
Grafing 2
Hefei 2
La Paz 2
Leawood 2
Mumbai 2
Nanchang 2
Pesaro 2
Pisa 2
San Polo in Chianti 2
Toronto 2
Turin 2
Venice 2
Verona 2
Washington 2
Acton 1
Agrigento 1
Albuquerque 1
Ankara 1
Auburn Hills 1
Beit Meri 1
Belize City 1
Benevento 1
Bologna 1
Bremerhaven 1
Bridgnorth 1
Brno 1
Totale 2.709
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 302
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 268
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 256
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 242
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 224
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. 211
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy 193
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data 190
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 190
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis 189
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 180
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 159
PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER 146
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY 138
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability 133
Biomarker expression and survival after primary chemotherapy for breast cancer. 129
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 123
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 103
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer 95
Totale 3.471
Categoria #
all - tutte 12.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020402 0 0 0 0 0 117 100 56 58 21 34 16
2020/2021441 51 16 34 35 39 27 58 45 28 36 40 32
2021/2022394 7 52 59 23 10 32 24 13 39 17 75 43
2022/2023679 88 82 32 56 45 59 21 36 215 4 8 33
2023/2024379 18 22 22 29 81 45 23 55 16 9 33 26
2024/2025429 28 21 10 79 169 122 0 0 0 0 0 0
Totale 3.471